Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1999
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A08AB01
|
| gptkbp:brand |
gptkb:orlistat
|
| gptkbp:contraindication |
cholestasis
chronic malabsorption syndrome |
| gptkbp:form |
capsule
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
lipase inhibitor
|
| gptkbp:powers |
120 mg
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
abdominal pain
flatulence fecal urgency oily stools |
| gptkbp:usedFor |
weight loss
obesity treatment |
| gptkbp:bfsParent |
gptkb:Roche
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xenical
|